tubulazole has been researched along with Fibrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Brabander, M; Distelmans, W; Heeres, J; Van Ginckel, R; Vanherck, W; Willebrords, R; Wouters, L | 1 |
| De Backer, G; De Brabander, M; Distelmans, W; Van den Winkel, P; Van Ginckel, R; Vanherck, W; Willebrords, R; Wouters, L | 1 |
2 other study(ies) available for tubulazole and Fibrosarcoma
| Article | Year |
|---|---|
Influence of the synthetic microtubule inhibitor erbulozole (P.I.N.N.) (R 55 104), a new tubulozole congener, and gamma irradiation on murine tumors in vivo.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Dioxolanes; Dioxoles; Drug Evaluation, Preclinical; Fibrosarcoma; Male; Mice; Microtubules; Neoplasm Transplantation; Time Factors | 1989 |
Interaction between the microtubule inhibitor tubulozole and gamma-irradiation in murine tumors in vivo.
Topics: Animals; Antineoplastic Agents; Cell Line; Cobalt Radioisotopes; Combined Modality Therapy; Dioxolanes; Dioxoles; Fibrosarcoma; Gamma Rays; Lung Neoplasms; Male; Mice; Neoplasm Transplantation | 1989 |